Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells

Cell Communication and Signaling

Volumn 6, Issue , 2008, Pages

  Emaduddin, Muhammad ^a   Edelmann, Mariola J ^a   Kessler, Benedikt M ^a   Feller, Stephan M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649736740     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-6-7     Document Type: Article

References (46)

1. Src family kinases in tumor progression and metastasis. JM Summy, GE Gallick, Cancer Metastasis Rev 2003 22 337 358 10.1023/A:1023772912750 12884910 (Pubitemid 36791891)
2. The hunting of the Src. GS Martin, Nat Rev Mol Cell Biol 2001 2 467 475 10.1038/35073094 11389470 (Pubitemid 33680585)
3. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy. FM Johnson, GE Gallick, Anticancer Agents Med Chem 2007 7 651 659 10.2174/187152007784111278 18045060 (Pubitemid 350237770)
4. The genomic landscapes of human breast and colorectal cancers. LD Wood, DW Parsons, S Jones, J Lin, T Sjoblom, RJ Leary, D Shen, SM Boca, T Barber, J Ptak, N Silliman, S Szabo, Z Dezso, V Ustyanksky, T Nikolskaya, Y Nikolsky, R Karchin, PA Wilson, JS Kaminker, Z Zhang, R Croshaw, J Willis, D Dawson, M Shipitsin, JK Willson, S Sukumar, K Polyak, BH Park, CL Pethiyagoda, PV Pant, et al. Science 2007 318 1108 1113 10.1126/science.1145720 17932254 (Pubitemid 350134889)
5. Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells. M Emaduddin, DC Bicknell, WF Bodmer, SM Feller, Proc Natl Acad Sci USA 2008 105 2358 2362 18258742 10.1073/pnas.0712176105 (Pubitemid 351520518)
6. Src continues aging: current and future clinical directions. S Kopetz, AN Shah, GE Gallick, Clin Cancer Res 2007 13 7232 7236 10.1158/1078-0432.CCR-07- 1902 18094400
7. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. BJ Mayer, H Hirai, R Sakai, Curr Biol 1995 5 296 305 10.1016/S0960-9822(95)00060-1 7780740
8. SH2 domains recognize specific phosphopeptide sequences. Z Songyang, SE Shoelson, M Chaudhuri, G Gish, T Pawson, WG Haser, F King, T Roberts, S Ratnofsky, RJ Lechleider, BG Neel, RB Birge, JE Fajardo, MM Chou, H Hanafusa, B Schaffhausen, LC Cantley, Cell 1993 72 767 778 10.1016/0092-8674(93)90404-E 7680959 (Pubitemid 23093884)
9. Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. Y Collette, H Dutartre, A Benziane, M Ramos, R Benarous, M Harris, D Olive, J Biol Chem 1996 271 6333 6341 10.1074/jbc.271.11. 6333 8626429 (Pubitemid 26095441)
10. Identification and characterization of a novel cytoskeleton-associated pp60src substrate. H Wu, AB Reynolds, SB Kanner, RR Vines, JT Parsons, Mol Cell Biol 1991 11 5113 5124 1922035 (Pubitemid 21895272)
11. Vinculin: a cytoskeletal target of the transforming protein of Rous sarcoma virus. BM Sefton, T Hunter, EH Ball, SJ Singer, Cell 1981 24 165 174 10.1016/0092-8674(81)90512-2 6263485 (Pubitemid 11157141)
12. PDGF induces reorganization of vimentin filaments. S Valgeirsdottir, L Claesson-Welsh, E Bongcam-Rudloff, U Hellman, B Westermark, CH Heldin, J Cell Sci 1998 111 Pt 14 1973 1980 9645945 (Pubitemid 28391063)
13. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. I Foucault, S Le Bras, C Charvet, C Moon, A Altman, M Deckert, Blood 2005 105 1106 1113 10.1182/blood-2003-08-2965 15345594 (Pubitemid 40170882)
14. GIT1 is a scaffold for ERK1/2 activation in focal adhesions. G Yin, Q Zheng, C Yan, BC Berk, J Biol Chem 2005 280 27705 27712 10.1074/jbc.M502271200 15923189 (Pubitemid 41076884)
15. TOM1L1 is a Lyn substrate involved in FcepsilonRI signaling in mast cells. J Zhang, K Suzuki, T Hitomi, RP Siraganian, J Biol Chem 2007 282 37669 37677 10.1074/jbc.M705168200 17977829
16. XB130, a novel adaptor protein for signal transduction. J Xu, XH Bai, M Lodyga, B Han, H Xiao, S Keshavjee, J Hu, H Zhang, BB Yang, M Liu, J Biol Chem 2007 282 16401 16412 10.1074/jbc.M701684200 17412687 (Pubitemid 47100390)
17. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site. R de Jong, J ten Hoeve, N Heisterkamp, J Groffen, Oncogene 1997 14 507 513 10.1038/sj.onc.1200885 9053848 (Pubitemid 27090952)
18. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury. YC Hwang, S Shaw, M Kaneko, H Redd, MB Marrero, R Ramasamy, FASEB J 2005 19 795 797 15746188 (Pubitemid 40617387)
19. Analysis of protein complexes using mass spectrometry. AC Gingras, M Gstaiger, B Raught, R Aebersold, Nat Rev Mol Cell Biol 2007 8 645 654 10.1038/nrm2208 17593931 (Pubitemid 47106612)
20. Tubulin is phosphorylated at tyrosine by pp60c-src in nerve growth cone membranes. WT Matten, M Aubry, J West, PF Maness, J Cell Biol 1990 111 1959 1970 1699949 10.1083/jcb.111.5.1959
21. An active Src kinase-beta-actin association is linked to actin dynamics at the periphery of colon cancer cells. E Avizienyte, M Keppler, E Sandilands, VG Brunton, SJ Winder, T Ng, MC Frame, Exp Cell Res 2007 313 3175 3188 10.1016/j.yexcr.2007.04.037 17651734 (Pubitemid 47299092)
22. Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases. A Pandey, B Blagoev, I Kratchmarova, M Fernandez, M Nielsen, TZ Kristiansen, O Ohara, AV Podtelejnikov, S Roche, HF Lodish, M Mann, Oncogene 2002 21 8029 8036 10.1038/sj.onc.1205988 12439753 (Pubitemid 35430613)
23. Identification of phosphotyrosine binding domain-containing proteins as novel downstream targets of the EphA8 signaling function. J Shin, C Gu, E Park, S Park, Mol Cell Biol 2007 27 8113 8126 17875921 10.1128/MCB.00794-07 (Pubitemid 350234227)
24. The specificities of protein kinase inhibitors: an update. J Bain, H McLauchlan, M Elliott, P Cohen, Biochem J 2003 371 199 204 12534346 10.1042/BJ20021535 (Pubitemid 36458094)
25. The selectivity of protein kinase inhibitors: a further update. J Bain, L Plater, M Elliott, N Shpiro, CJ Hastie, H McLauchlan, I Klevernic, JS Arthur, DR Alessi, P Cohen, Biochem J 2007 408 297 315 17850214 10.1042/BJ20070797
26. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. RA Blake, MA Broome, X Liu, J Wu, M Gishizky, L Sun, SA Courtneidge, Mol Cell Biol 2000 20 9018 9027 11074000 10.1128/MCB.20.23.9018- 9027.2000 (Pubitemid 32245931)
27. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. P Traxler, G Bold, J Frei, M Lang, N Lydon, H Mett, E Buchdunger, T Meyer, M Mueller, P Furet, J Med Chem 1997 40 3601 3616 10.1021/jm970124v 9357527 (Pubitemid 27465092)
28. Structural and evolutionary division of phosphotyrosine binding (PTB) domains. MT Uhlik, B Temple, S Bencharit, AJ Kimple, DP Siderovski, GL Johnson, J Mol Biol 2005 345 1 20 10.1016/j.jmb.2004.10.038 15567406 (Pubitemid 39572821)
29. Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. A Wolf-Yadlin, N Kumar, Y Zhang, S Hautaniemi, M Zaman, HD Kim, V Grantcharova, DA Lauffenburger, FM White, Mol Syst Biol 2006 2 54 17016520 10.1038/msb4100094 (Pubitemid 46061069)
30. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. A Wolf-Yadlin, S Hautaniemi, DA Lauffenburger, FM White, Proc Natl Acad Sci USA 2007 104 5860 5865 17389395 10.1073/pnas.0608638104 (Pubitemid 47175624)
31. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. K Rikova, A Guo, Q Zeng, A Possemato, J Yu, H Haack, J Nardone, K Lee, C Reeves, Y Li, Y Hu, Z Tan, M Stokes, L Sullivan, J Mitchell, R Wetzel, J Macneill, JM Ren, J Yuan, CE Bakalarski, J Villen, JM Kornhauser, B Smith, D Li, X Zhou, SP Gygi, TL Gu, RD Polakiewicz, J Rush, MJ Comb, Cell 2007 131 1190 1203 10.1016/j.cell.2007.11.025 18083107 (Pubitemid 350235027)
32. Signaling networks assembled by oncogenic EGFR and c-Met. A Guo, J Villen, J Kornhauser, KA Lee, MP Stokes, K Rikova, A Possemato, J Nardone, G Innocenti, R Wetzel, Y Wang, J MacNeill, J Mitchell, SP Gygi, J Rush, RD Polakiewicz, MJ Comb, Proc Natl Acad Sci USA 2008 105 692 697 18180459 10.1073/pnas.0707270105 (Pubitemid 351171770)
33. Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer. A Kong, P Leboucher, R Leek, V Calleja, S Winter, A Harris, PJ Parker, B Larijani, Cancer Res 2006 66 2834 2843 10.1158/0008-5472.CAN-05-2994 16510606
34. High-throughput phosphotyrosine profiling using SH2 domains. K Machida, CM Thompson, K Dierck, K Jablonowski, S Karkkainen, B Liu, H Zhang, PD Nash, DK Newman, P Nollau, T Pawson, GH Renkema, K Saksela, MR Schiller, DG Shin, BJ Mayer, Mol Cell 2007 26 899 915 10.1016/j.molcel.2007.05.031 17588523 (Pubitemid 46929095)
35. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. BA Liu, K Jablonowski, M Raina, M Arce, T Pawson, PD Nash, Mol Cell 2006 22 851 868 10.1016/j.molcel.2006.06.001 16793553
36. The C2 domain of PKCdelta is a phosphotyrosine binding domain. CH Benes, N Wu, AE Elia, T Dharia, LC Cantley, SP Soltoff, Cell 2005 121 271 280 10.1016/j.cell.2005.02.019 15851033 (Pubitemid 40546394)
37. A quantitative protein interaction network for the ErbB receptors using protein microarrays. RB Jones, A Gordus, JA Krall, G MacBeath, Nature 2006 439 168 174 10.1038/nature04177 16273093 (Pubitemid 43083134)
38. Classification of human colorectal adenocarcinoma cell lines. A Leibovitz, JC Stinson, WB McCombs 3rd, CE McCoy, KC Mazur, ND Mabry, Cancer Res 1976 36 4562 4569 1000501
39. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. MM Bradford, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
40. c-Abl kinase regulates the protein binding activity of c-Crk. SM Feller, B Knudsen, H Hanafusa, EMBO J 1994 13 2341 2351 8194526
41. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways. SM Feller, B Knudsen, H Hanafusa, Oncogene 1995 10 1465 1473 7731701
42. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions. B Hock, B Bohme, T Karn, S Feller, H Rubsamen-Waigmann, K Strebhardt, Oncogene 1998 17 255 260 10.1038/sj.onc.1201907 9674711 (Pubitemid 28371900)
43. Herpesvirus ateles gene product Tio interacts with nonreceptor protein tyrosine kinases. JC Albrecht, U Friedrich, C Kardinal, J Koehn, B Fleckenstein, SM Feller, B Biesinger, J Virol 1999 73 4631 4639 10233922 (Pubitemid 29246721)
44. Protein Sequencing and Identification Using Tandem Mass Spectrometry. M Kinter, SN Sherman, New York: John Wiley and Sons, Inc 2000 147 164
45. Ultra-fast tandem mass spectrometry scanning combined with monolithic column liquid chromatography increases throughput in proteomic analysis. M Batycka, NF Inglis, K Cook, A Adam, D Fraser-Pitt, DG Smith, L Main, A Lubben, BM Kessler, Rapid Commun Mass Spectrom 2006 20 2074 2080 10.1002/rcm.2563 16773668 (Pubitemid 44049032)
46. Rules governing protein identification by mass spectrometry. GK Taylor, DR Goodlett, Rapid Commun Mass Spectrom 2005 19 3420 10.1002/rcm.2225 16252315 (Pubitemid 41691915)